Regeneron Pharmaceuticals (REGN) Net Cash Flow Growth (5y) (2014 - 2026)
Regeneron Pharmaceuticals (REGN) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.44% |
| Dec 31, 2025 | -0.32% |
| Sep 30, 2025 | 26.12% |
| Jun 30, 2025 | -37.92% |
| Mar 31, 2025 | 0.44% |
| Dec 31, 2024 | 15.45% |
| Sep 30, 2024 | -24.58% |
| Jun 30, 2024 | -0.55% |
| Mar 31, 2024 | -20.39% |
| Dec 31, 2023 | 8.73% |
| Sep 30, 2023 | 4.40% |
| Jun 30, 2023 | -81.09% |
| Mar 31, 2023 | 31.38% |
| Dec 31, 2022 | -83.27% |
| Sep 30, 2022 | 15.04% |
| Jun 30, 2022 | 22.27% |
| Mar 31, 2022 | 10.76% |
| Dec 31, 2021 | -7.97% |
| Sep 30, 2021 | 37.79% |
| Jun 30, 2021 | 71.87% |